Catalyst Trusteeship Limited, acting as Debenture Trustee, has disclosed the creation of a pledge over equity shares of Medplus Health Services Limited. This action, undertaken for the benefit of debenture holders, involves 34,00,000 equity shares, representing 2.83% of the total share capital. The disclosure is made in accordance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Disclosure of Pledge Creation
Catalyst Trusteeship Limited, in its capacity as the Debenture Trustee, has filed a disclosure concerning the creation of a pledge over equity shares of Medplus Health Services Limited, the ‘Target Company’. This disclosure is mandated under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Key Details of the Pledge
The pledge involves 34,00,000 equity shares of Medplus Health Services Limited. This represents 2.83% of the total share capital, as well as 2.83% of the total diluted share capital of the company. The pledge was created on September 29, 2026, and October 23, 2026, as part of the arrangement for the benefit of the debenture holders.
Shareholding Before and After
Prior to this pledge, Catalyst Trusteeship Limited’s holding in Medplus Health Services Limited, on behalf of debenture holders, stood at 2,07,50,400 shares, accounting for 17.27% of the total share capital and 17.26% of the diluted share capital. Following the creation of the pledge, the total holding remains at 2,07,50,400 shares, with the shares now encumbered. The total shares carrying voting rights after this action remain at 2,41,50,400, representing 20.10% of the total share capital and 20.09% of the diluted share capital.
Source: BSE
